In an interaction with Maulik Patel, CMD, Epigral Ltd
In an interaction with Maulik Patel, CMD, Epigral Ltd

In an interaction with Maulik Patel, CMD, Epigral Ltd

We have witnessed improvement quarter on quarter, even when the overall chemical industry was under pressure, says Maulik Patel, CMD, Epigral Ltd.

Siddharth Mane Article rating: 4.0

We have witnessed improvement quarter on quarter, even when the overall chemical industry was under pressure, says Maulik Patel, CMD, Epigral Ltd.

 

DSIJ MINDSHARE

Mkt Commentary10-May, 2024

Multibaggers10-May, 2024

Penny Stocks10-May, 2024

Multibaggers10-May, 2024

Interviews10-May, 2024

Knowledge

General10-May, 2024

General10-May, 2024

MF9-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR